Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 2]
Pharmac Funds Treatment For Rare Disorders
Monday, 12 January 2026, 11:54 am | PHARMAC
Clinicians have supported this decision, saying it will make access to treatment simpler for their patients. More >>
Pharmac Will Not Proceed With Proposed Changes To How It Manages The Options For Investment List
Wednesday, 17 December 2025, 11:13 am | PHARMAC
“People told us that while they understood our aim was to improve transparency, they did not want us to remove funding applications from the OFI,” says Pharmac’s Director Pharmaceuticals, Adrienne Martin. More >>
Pharmac Proposes Improved Access To Emergency Medicines In Rural And Remote Communities
Monday, 1 December 2025, 2:06 pm | PHARMAC
Pharmac is working with Health NZ, ACC, ambulance services, rural GPs, midwives, and palliative care providers to understand how the proposed changes would work in practice. More >>
Easier Access To HIV Medicines From Next Year
Thursday, 27 November 2025, 11:34 am | PHARMAC
Pharmac’s Manager Pharmaceutical Funding, Claire Pouwels, says about 3,500 people will benefit from the switch to three-month dispensing. More >>
Pharmac Proposes Funding For Rare Disorder Treatment
Wednesday, 26 November 2025, 11:14 am | PHARMAC
If approved following the public consultation, approximately 10 people with these rare disorders would benefit from access to the medicine in the first year of funding. More >>
Pharmac Proposes Funding Another ADHD Medicine To Improve Supply
Thursday, 20 November 2025, 1:06 pm | PHARMAC
If approved, the Rubifen LA (long-acting) brand of methylphenidate will be funded from 1 July 2026. More >>
Dental Treatment Proposed For Public Funding
Wednesday, 12 November 2025, 2:14 pm | PHARMAC
This follows public consultation and is expected to benefit children, and those who may find some traditional dental procedures challenging. More >>
Pharmac To Fund Five Medicines For Multiple Sclerosis, Breast Cancer, Eye Conditions, And Lung Cancer
Wednesday, 12 November 2025, 11:15 am | PHARMAC
The funding decision includes new treatments and faster-to-administer versions of existing medicines, secured through a multiproduct agreement with pharmaceutical supplier Roche. More >>
Pharmac Consults On Changes To Simplify Biologic Medicine Funding Criteria
Thursday, 6 November 2025, 2:37 pm | PHARMAC
The proposed changes aim to reduce administrative workload for clinicians, improve consistency across biologic treatments, and respond to feedback received during previous consultation. More >>
Pharmac To Change Brand Of Fulvestrant Injection For New Zealanders With Breast Cancer
Thursday, 30 October 2025, 11:53 am | PHARMAC
Faslodex will be delisted on 1 May 2026, and Fulvestrant EVER Pharma will then hold Principal Supply Status until 30 June 2028. More >>
Pharmac Reset Programme Completes First 90-Day Plan
Wednesday, 29 October 2025, 1:30 pm | PHARMAC
The first 90-day plan, which ran from 1 July to 30 September 2025, began with the appointment of a 10-member Consumer and Patient Working Group, chaired by patient advocate Dr Malcolm Mulholland. More >>
Pharmac To Fund An Additional ADHD Medicine To Increase Supply And Access
Wednesday, 29 October 2025, 11:17 am | PHARMAC
Pharmac received 149 responses to its September consultation. Most people supported the proposal, saying it would reduce stress, improve access, and help avoid treatment delays. More >>
Pharmac Proposes Greater Transparency For Medicine Funding Decisions
Monday, 20 October 2025, 11:12 am | PHARMAC
Pharmac is committed to consultation and will not decline any applications without hearing from the public. More >>
Dental Treatment Proposed For Public Funding
Thursday, 16 October 2025, 2:56 pm | PHARMAC
Silver diamine fluoride is a topical treatment that halts the progression of tooth decay and reduces tooth sensitivity. It comes in a liquid form that is applied to the tooth, making it less painful and invasive than a filling. More >>
Pharmac Cuts Red Tape To Improve Access To Medicines For Thousands Of New Zealanders
Thursday, 16 October 2025, 11:43 am | PHARMAC
A Special Authority is a type of funding restriction used by Pharmac to ensure that certain medicines are targeted to people who would benefit most from them. More >>
Pharmac Proposes Changes To Make It Easier To Access HIV Medicines
Thursday, 2 October 2025, 11:22 am | PHARMAC
Pharmac is consulting on a proposal to remove Special Authority and Hospital Indication criteria for all funded antiretroviral medicines for HIV. More >>
Pharmac Proposes Funding Five Medicines And More Convenient Treatment Options To Ease Pressure On Health Services
Wednesday, 24 September 2025, 11:06 am | PHARMAC
Pharmac is consulting on a multiproduct agreement with Roche that includes new treatments and faster-to-administer types of existing medicines. If approved, the medicines would be funded from 1 December 2025. More >>
Pharmac Proposes Funding A New Brand Of ADHD Medicine
Wednesday, 17 September 2025, 11:09 am | PHARMAC
If approved, the proposal would see Methylphenidate Sandoz XR funded from 1 December 2025. This is a generic equivalent to the Concerta brand and would be available in the same strengths. More >>
Pharmac Confirms Continued Access To Comirnaty COVID-19 Vaccine
Monday, 1 September 2025, 11:11 am | PHARMAC
A new prefilled syringe for adults will also be introduced, making it easier for health professionals to administer the vaccine. More >>
Pharmac To Update Access And Supply Of COVID-19 Treatments
Monday, 11 August 2025, 1:34 pm | PHARMAC
From 1 September 2025 the antivirals, nirmatrelvir with ritonavir (branded as Paxlovid) and remdesivir (branded as Veklury) will be funded for all people aged 50 years or over with an active COVID-19 infection who are at high risk of hospitalisation or ... More >>
